| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.44 | 0.008 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |